Patents by Inventor Jiefei WANG

Jiefei WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Two-dimensional (2D) bismuth nanocomposite, and preparation method and use thereof
    Patent number: 11667541
    Abstract: The disclosure relates to a two-dimensional (2D) bismuth nanocomposite, and a preparation method and use thereof, and belongs to the field of nanobiotechnology. The 2D bismuth nanocomposite of the disclosure is an ultra-thin bismuth nanosheet that is loaded with platinum nanoparticles and modified with indocyanine green (ICG) and surface targeting polypeptide Ang-2. The 2D bismuth nanocomposite Bi@Pt/ICG-Ang2 of the disclosure can not only realize the targeted photothermal and photodynamic combination therapy for tumors, but also realize the dual-mode imaging combining CT and fluorescence imaging.
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: June 6, 2023
    Assignee: HENAN UNIVERSITY
    Inventors: Bingyang Shi, Jiefei Wang, Ping Shangguan, Yong Zhong, Zhongjie Wang, Xiaoyu Chen
  • TWO-DIMENSIONAL (2D) BISMUTH NANOCOMPOSITE, AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20210198118
    Abstract: The disclosure relates to a two-dimensional (2D) bismuth nanocomposite, and a preparation method and use thereof, and belongs to the field of nanobiotechnology. The 2D bismuth nanocomposite of the disclosure is an ultra-thin bismuth nanosheet that is loaded with platinum nanoparticles and modified with indocyanine green (ICG) and surface targeting polypeptide Ang-2. The 2D bismuth nanocomposite Bi@Pt/ICG-Ang2 of the disclosure can not only realize the targeted photothermal and photodynamic combination therapy for tumors, but also realize the dual-mode imaging combining CT and fluorescence imaging.
    Type: Application
    Filed: December 21, 2020
    Publication date: July 1, 2021
    Inventors: Bingyang SHI, Jiefei WANG, Ping SHANGGUAN, Yong ZHONG, Zhongjie WANG, Xiaoyu CHEN